MedTrace Logo

Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers

NCT02815176 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-06-29

No results posted yet for this study

Summary

Thrombotic biomarkers and angiographic characteristics were compared among the de novo patients of central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV) and the control.

Conditions

  • Central Serous Chorioretinopathy
  • Polypoidal Choroidal Vasculopathy

Interventions

OTHER

Blood sampling

Sampling the blood including DNA to investigate the thrombotic profile

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Kunho Bae, MD · Department of ophthalmology, Samsung medical center, Seoul, Korea

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02815176 on ClinicalTrials.gov